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SUMMARY A method of treatment of tinea capitis is presented in a case of a 
10-year-old boy who was referred to the pediatric surgical unit for the treat-
ment of a skin lesion on the scalp, which had persisted for more than two 
months. The initial dermatologic examination led to the clinical diagnosis of 
inflammation of the scalp, while mycological analysis revealed an uncom-
mon dermatophyte agent, Microsporum gypseum, in the culture. The lesion 
was subsequently treated with local and oral antifungal agents, but antifun-
gal therapy was discontinued due to the resulting liver dysfunction and was 
replaced by treatment with a silver impregnated hydrofiber dressing. Dur-
ing one-month treatment, the patient’s scalp lesion cleared completely. The 
treatment of tinea capitis is discussed.
KeY woRDS: kerion celsi, Microsporum gypseum, tinea capitis, silver dress-
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InTRoDUCTIon
Tinea capitis is a worldwide spread infection that 
involves the scalp hair follicles and intervening skin, 
affecting primarily prepubertal children (1). Depend-
ing on the causative organism, the type of hair inva-
sion, and the specific host T lymphocyte inflamma-
tory response, four major clinical patterns of tinea ca-
pitis have been outlined (2): noninflammatory black 
dot pattern, noninflammatory seborrheic dermatitis 
type, inflammatory kerion, and favus. Kerion, an in-
frequent type of tinea capitis, is the result of a severe 
inflammatory response to dermatophyte infection, 
occurring predominantly in children (3). Because ke-
rion with its pus-filled swellings can look like bacterial 
abscesses, the gold standard examination of fungal 
culture plays a crucial role in the early recognition of 
a potential infection of dermatophytes (4).
Here we present a case of kerion celsi caused by 
Microsporum (M.) gypseum, where treatment with sil-
ver impregnated hydrofiber dressing (Aquacel® Ag, 
ConvaTec) was successfully implemented.
CASe RepoRT
A 10-year-old boy, previously healthy and with-
out a history of any severe disease, presented to the 
family doctor with a several-day history of mildly el-
evated, non-suppurative nodular mass with alope-
cia in the right retroauricular scalp region, and local 
lymphadenopathy. The mass was approximately 1 
cm in diameter, with no edema or hyperemia, and 
slightly painful upon pressure. The diagnosis of 
nonspecific cutaneous infection was made. Initially, 
he received a 1-week course of oral antibiotic, cefu-
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roxime (Xorimax® tbl, Sandoz GmbH, 250 mg twice 
daily), but the skin lesion worsened. Two weeks later, 
the patient was examined by a dermatologist who 
found erythematous pruritic papules, alopecic areas 
about 1.5 cm in diameter covered with thick layers of 
scales, and purulent secretion from follicular open-
ings. Scale and hair samples were obtained and culti-
vated on Sabouraud agar with chloramphenicol and 
cycloheximide for mycological culture. Therapy with 
antiseptic solution (Plivasept®, Pliva) along with be-
tamethasone/gentamicin cream (Belogent®, Belupo) 
was introduced. In two weeks, M. gypseum grew in 
the mycological culture. Oral terbinafine (Lamisil® tbl, 
Novartis, 125 mg daily) was administered along with 
Plivasept® and isoconazole nitrate/diflucortolone val-
erate (Travocort®, MSD) cream used topically. 
After two weeks of treatment, there was a marked 
deterioration of the scalp lesion and, upon his moth-
er’s request, the child was referred to pediatric sur-
gery. On admission, physical examination revealed 
a solitary painful, elevated, boggy, granulomatous 
mass measuring 5 cm in diameter, studded with sev-
eral papules, pustules along with purulent exudate 
over his retroauricular region (Fig. 1A). Hairs on the 
infected area were brittle and broken. Because of the 
distance from home, the patient was hospitalized 
for further treatment. Immediately upon admission, 
incision biopsy for histopathologic and cytologic 
analysis was done. Histologic analysis revealed a pro-
nounced inflammatory tissue reaction, granulation 
tissue with a number of neutrophils and eozinophils 
in the upper dermis, while fungal hyphae could not 
be demonstrated. During the treatment, laboratory 
tests showed slightly elevated liver enzyme levels 
(AST 59 H (ref. interval 14-39), ALT 44 H (ref. interval 
11-37)). Oral and topical antifungal therapy was dis-
continued and the lesion was cleaned with saline and 
treated locally only with Aquacel® Ag silver impreg-
nated hydrofiber dressing. The dressing was applied 
as a single small dressing. In the first two weeks, the 
dressing was changed daily, and then every 3-4 days 
for another two weeks. After a week, the lesion im-
proved significantly (Fig. 1B), and upon completion 
of the four-week treatment with Aquacel® Ag, the 
kerion healed completely (Fig. 1C). Repeated com-
plete blood cell counts and hepatic enzymes were all 
within the normal ranges and the fungal culture was 
negative. Several patches of alopecia remained on 
the previous lesion sites. However, at follow up after a 
few months, hair regrowth was noted (Fig. 1D).
DISCUSSIon 
In the present report, we describe a case of kerion 
celsi caused by M. gypseum, a geophilic species with 
low contagious potential that generally causes tinea 
corporis. Only a few cases of M. gypseum as an agent 
of tinea capitis have been described in the literature 
so far (5,6). In Europe, the most common etiologic 
agent of tinea capitis is the zoophilic species M. ca-
nis, with the highest incidence in the Mediterranean 
countries (7). The same situation was observed in Cro-
atia, where in the last eight years, 58 cases of typical 
kerion celsi have been recorded, with M. canis isolat-
ed in 32% and M. gypseum in only 5% of patients (8). 
Nearly the same pattern has been reported in other 
European countries (7). 
Tinea capitis always requires systemic antifungal 
treatment, while topical therapy is only used as ad-
juvant therapy. The gold standard for systemic treat-
ment is griseofulvin, although the long duration of 
treatment (6-12 weeks or longer) may lead to reduced 
compliance. The newer oral antifungal agents, terbi-
nafine, itraconazole and fluconazole have the same 
efficacy as griseofulvin (9). Griseofulvin appears to be 
superior to terbinafine in treating Microsporum tinea 
capitis; although Silm and Karelson observed an ef-
fective cure rate of 65.4% when using terbinafine for 
tinea capitis caused by M. canis (10). Recently, it has 
been shown that a dose of terbinafine higher than 
labeled by the manufacturer might be required to 
treat Microsporum tinea capitis, thus the optimal dos-
ing and duration regimen has yet to be established 
(11). Since griseofulvin is not available in Croatia, we 
started treating our patient with terbinafine; howev-
er, due to the elevation of liver enzyme levels, further 
systemic antifungal treatment was discontinued. It is 
Figure 1. Inflammatory tinea capitis caused by Mi-
crosporum gypseum. Kerion celsi in the right retroau-
ricular region of the scalp: on the patient’s admission 
to pediatric surgery (A); after 10 days (B); after com-
pleting 4-week treatment with Aquacel® Ag dressing 
(C); and at follow-up 4 months after therapy (D). 
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well known that oral antifungal drugs may be associ-
ated with some potential for liver dysfunction/dam-
age and even severe hepatic toxicity (12). After dis-
continuation of the antifungal systemic treatment in 
our patient, the repeated test showed that all hepatic 
enzymes were within the normal ranges. Thus, we 
assumed that even a short 2-week terbinafine treat-
ment might have a mild hepatotoxic effect. 
Although kerion with its pus-filled swellings might 
be misdiagnosed as bacterial abscesses, surgical inter-
vention is inappropriate. It should be stressed that in 
children with inflammatory scalp lesions resembling 
bacterial abscesses, mycological examination should 
be done in order to establish the exact diagnosis, in-
troduce appropriate treatment and prevent unneces-
sary surgical therapy. However, our patient was re-
ferred upon his mother’s request to the Department 
of Pediatric Surgery, where conservative treatment 
with Aquacel® Ag dressing was successfully applied. 
This is a new hydrofiber wound dressing consisting 
of soft non-woven sodium carboxymethylcellulose 
fibers integrated with ionic silver, which is released 
within the dressing for up to two weeks (13). Silver or 
silver ions have a strong inhibitory and bactericidal 
effect and a broad spectrum of antimicrobial activi-
ties and, consequently, Aquacel® Ag has been used as 
an effective and safe dressing for a variety of wound 
types. Wright et al. have shown that silver dressings 
are effective against a broad spectrum of common 
fungal wound pathogens as well (14). Recently, it has 
been shown that dissolved silver is fungicidal in vitro, 
while silver nanoparticles have a strong antifungal ef-
fect that is further enhanced when combining with 
fluconazole or griseofulvin (15).
ConCLUSIon
We report this case because an infection with M. 
gypseum, which is relatively rare in humans and par-
ticularly in children, was successfully treated with 
Aquacel® Ag dressing. To the best of our knowledge, 
this is the first report on successful treatment of ke-
rion with a silver impregnated dressing, so it might 
be an alternative therapy in patients with an already 
existing liver disease or just acquired liver damage 
due to antifungal oral agents prescribed, as was the 
case in our patient.
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